EVGEN PHARMA
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products.
EVGEN PHARMA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2007-01-01
Address:
Wilmslow, Cheshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.evgen.com
Total Employee:
1+
Status:
Active
Contact:
+44 151 705 3532
Total Funding:
16.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Board_member
2006-11-01
Current Employees Featured
Huw Jones Chief Executive Officer @ Evgen Pharma
Chief Executive Officer
2020-10-01
Founder
Stock Details
Investors List
Acceleris Capital
Acceleris Capital investment in Venture Round - Evgen Pharma
Seneca Partners
Seneca Partners investment in Venture Round - Evgen Pharma
The North West Fund
The North West Fund investment in Venture Round - Evgen Pharma
Sarum Partners
Sarum Partners investment in Venture Round - Evgen Pharma
Enterprise Ventures
Enterprise Ventures investment in Venture Round - Evgen Pharma
The North West Fund
The North West Fund investment in Series A - Evgen Pharma
Rising Stars Growth Fund
Rising Stars Growth Fund investment in Series A - Evgen Pharma
Imprimatur Capital
Imprimatur Capital investment in Seed Round - Evgen Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-22 | Evgen Pharma names chief business officer |
Official Site Inspections
http://www.evgen.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K
- Host name: pl1.jpcinet.co.uk
- IP address: 212.113.198.195
- Location: Crawley United Kingdom
- Latitude: 51.1149
- Longitude: -0.1841
- Timezone: Europe/London
- Postal: RH11
More informations about "Evgen Pharma"
Evgen Pharma - Crunchbase Company Profile & Funding
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on …See details»
TheraCryf | A clinical stage therapeutics company
Formerly Evgen Pharma plc, the Company acquired Chronos Therapeutics in April 2024. TheraCryf, the new name for the Group, reflects a wider mission and broader portfolio. The …See details»
Evgen Pharma - Org Chart, Teams, Culture & Jobs
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions and the lead product is SFX-01. Industries. Pharmaceutical. Headquarters. England, United Kingdom. Stage. …See details»
Evgen Pharma Information - RocketReach
Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. Our pipeline is based on our proprietary Sulforadex® technology, and includes a …See details»
Governance Evgen Pharma plc London S.E. - MarketScreener.com
Find the composition of the Board of Directors of Evgen Pharma plc (London S.E. Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»
REALISING THE CLINICAL POTENTIAL OF SULFORAPHANE
Evgen is a clinical stage drug development company focussed on the development of sulforaphane-based compounds, a new class of pharmaceuticals which are synthesised in a …See details»
Evgen Pharma - Contacts, Employees, Board Members
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. New. Resources. Advanced Search. Start Free Trial . Talk With …See details»
TheraCryf Company Profile - Office Locations, Competitors ... - Craft
TheraCryf (formerly known as Evgen Pharma) is a company that develops therapeutics for oncology and behavioral brain disorders. Its pipeline includes clinical and preclinical therapies …See details»
Evgen Pharma - Funding, Financials, Valuation & Investors
Evgen Pharma is registered under the ticker LSE:EVG . Evgen Pharma is funded by 7 investors. Acceleris Capital and Seneca Partners are the most recent investors. Evgen Pharma has …See details»
Evgen - VentureRadar
Merseyside based company, Evgen, is developing Sulforadex®, a patented pharmaceutical composition with enormous potential in the prevention and treatment of prostate cancer and …See details»
Evgen Pharma plc (Evgen or the Company or the Group) - Theracryf
Evgen Pharma PLC Dr Huw Jones, CEO +44 1625 466591 Toni Hänninen, CFO Cavendish Capital Markets (Nominated Advisor and Broker) Geoff Nash / Teddy Whiley (Corporate …See details»
Company Theracryf Plc Deutsche Boerse AG - MarketScreener.com
Mar 24, 2025 Theracryf PLC, formerly Evgen Pharma plc, is a clinical-stage therapeutics company. The Company is engaged in developing a new generation of therapeutics in …See details»
Evgen Pharma – Acquisition, Fundraising and Change of Name
Mar 20, 2024 Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane-based medicines for the treatment of multiple diseases, announces …See details»
Evgen Pharma – Seneca Growth Capital VCT Plc
Evgen is based in Liverpool, at the Liverpool Science Park and was founded in 2007 by Dr Stephen Franklin. Evgen is a clinical stage drug development company whose lead …See details»
Evgen - Products, Competitors, Financials, Employees, …
Evgen is a clinical stage drug development company operating in the pharmaceutical industry. Use the CB Insights Platform to explore Evgen's full profile. Evgen - Products, Competitors, …See details»
Evgen Pharma plc - Theracryf
Evgen Pharma plc (“Evgen” or “the Company” or “the Group”) Half year Report Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane-based …See details»
Company Evgen Pharma plc London S.E. - MarketScreener.com
Oct 20, 2015 Theracryf PLC, formerly Evgen Pharma plc, is a clinical-stage therapeutics company. The Company is engaged in developing a new generation of therapeutics in …See details»
FDA Touts EvGen, IMEDS Programs Ensuring Patient Safety - Med …
Jan 19, 2017 The EvGen Collaborative helps to realize that potential by allowing clinical research to be "embedded seamlessly within real-world clinical practice," bringing about "a …See details»
LEADING THE DEVELOPMENT OF SULFORAPHANE BASED …
Evgen benefits from the support of a number of academic. and clinical collaborators that are interested in the potential . of sulforaphane and SFX-01. The University of Auckland has …See details»
Evgen Pharma plc Half year Report - Theracryf
Evgen Pharma is a clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases. The Company's core technology is …See details»